Annual CAPEX
N/A
31 December 2023
Summary:
TherapeuticsMD annual capital expenditures is not available.TXMD CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
TherapeuticsMD quarterly capital expenditures is not available.TXMD Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
TherapeuticsMD TTM capital expenditures is not available.TXMD TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXMD CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
TXMD CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time |
TherapeuticsMD CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2022 | $355.00 K(-84.0%) | $74.00 K(-1157.1%) | $355.00 K(-80.2%) |
Sept 2022 | - | -$7000.00(-109.2%) | $1.79 M(-9.5%) |
June 2022 | - | $76.00 K(-64.2%) | $1.98 M(-0.7%) |
Mar 2022 | - | $212.00 K(-86.0%) | $2.00 M(-10.2%) |
Dec 2021 | $2.22 M(+39.1%) | $1.51 M(+731.9%) | $2.22 M(+84.8%) |
Sept 2021 | - | $182.00 K(+104.5%) | $1.20 M(-6.2%) |
June 2021 | - | $89.00 K(-79.7%) | $1.28 M(-19.5%) |
Mar 2021 | - | $438.00 K(-11.3%) | $1.59 M(-0.3%) |
Dec 2020 | $1.60 M(-93.3%) | $494.00 K(+88.5%) | $1.60 M(-92.7%) |
Sept 2020 | - | $262.00 K(-34.3%) | $21.84 M(-4.5%) |
June 2020 | - | $399.00 K(-9.9%) | $22.88 M(-3.3%) |
Mar 2020 | - | $443.00 K(-97.9%) | $23.67 M(-0.9%) |
Dec 2019 | $23.89 M(+12.1%) | $20.73 M(+1492.2%) | $23.89 M(+551.9%) |
Sept 2019 | - | $1.30 M(+9.4%) | $3.67 M(-83.9%) |
June 2019 | - | $1.19 M(+78.7%) | $22.70 M(+4.0%) |
Mar 2019 | - | $665.90 K(+31.3%) | $21.82 M(+2.3%) |
Dec 2018 | $21.32 M(+2478.0%) | $507.20 K(-97.5%) | $21.32 M(+0.7%) |
Sept 2018 | - | $20.33 M(+6430.1%) | $21.17 M(+2241.2%) |
June 2018 | - | $311.40 K(+84.3%) | $904.10 K(+5.0%) |
Mar 2018 | - | $169.00 K(-51.9%) | $860.80 K(+4.1%) |
Dec 2017 | $827.10 K(-33.4%) | $351.50 K(+386.8%) | $827.10 K(-4.7%) |
Sept 2017 | - | $72.20 K(-73.1%) | $867.60 K(-12.1%) |
June 2017 | - | $268.10 K(+98.2%) | $986.50 K(-18.6%) |
Mar 2017 | - | $135.30 K(-65.5%) | $1.21 M(-2.4%) |
Dec 2016 | $1.24 M(+112.4%) | $392.00 K(+105.1%) | $1.24 M(-4.5%) |
Sept 2016 | - | $191.10 K(-61.3%) | $1.30 M(+13.2%) |
June 2016 | - | $493.20 K(+198.9%) | $1.15 M(+61.2%) |
Mar 2016 | - | $165.00 K(-63.4%) | $712.50 K(+21.9%) |
Dec 2015 | $584.40 K(-5.3%) | $450.80 K(+1050.0%) | $584.40 K(+11.0%) |
Sept 2015 | - | $39.20 K(-31.8%) | $526.70 K(+12.6%) |
June 2015 | - | $57.50 K(+55.8%) | $467.80 K(-12.3%) |
Mar 2015 | - | $36.90 K(-90.6%) | $533.40 K(-13.6%) |
Dec 2014 | $617.40 K(+28.7%) | $393.10 K(-2095.4%) | $617.50 K(+46.1%) |
Sept 2014 | - | -$19.70 K(-116.0%) | $422.80 K(-28.2%) |
June 2014 | - | $123.10 K(+1.7%) | $588.80 K(+18.5%) |
Mar 2014 | - | $121.00 K(-39.0%) | $496.90 K(+3.6%) |
Dec 2013 | $479.80 K(+76.1%) | $198.40 K(+35.6%) | $479.80 K(+20.9%) |
Sept 2013 | - | $146.30 K(+368.9%) | $396.80 K(+35.9%) |
June 2013 | - | $31.20 K(-70.0%) | $292.00 K(-12.0%) |
Mar 2013 | - | $103.90 K(-10.0%) | $331.90 K(+21.8%) |
Dec 2012 | $272.50 K | $115.40 K(+178.1%) | $272.50 K(+64.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2012 | - | $41.50 K(-41.6%) | $166.00 K(+30.4%) |
June 2012 | - | $71.10 K(+59.8%) | $127.30 K(+78.8%) |
Mar 2012 | - | $44.50 K(+400.0%) | $71.20 K(+89.4%) |
Dec 2011 | $37.60 K(+37.7%) | $8900.00(+217.9%) | $37.60 K(+31.0%) |
Sept 2011 | - | $2800.00(-81.3%) | $28.70 K(+10.8%) |
June 2011 | - | $15.00 K(+37.6%) | $25.90 K(+137.6%) |
Mar 2011 | - | $10.90 K(-92.3%) | $10.90 K(-98.7%) |
Dec 2010 | $27.30 K(-96.8%) | - | - |
Dec 2009 | $841.30 K(+1358.1%) | $141.30 K(-79.8%) | $841.30 K(+20.2%) |
Sept 2009 | - | $700.00 K(-1190.3%) | $700.00 K(>+9900.0%) |
Dec 2007 | - | -$64.20 K(-255.1%) | $0.00(-100.0%) |
Sept 2007 | - | $41.40 K(>+9900.0%) | $121.90 K(+306.3%) |
June 2007 | - | $0.00(-100.0%) | $30.00 K(-57.1%) |
Mar 2007 | - | $22.80 K(-60.5%) | $70.00 K(+21.3%) |
Dec 2006 | $57.70 K(-37.4%) | $57.70 K(-214.3%) | $57.70 K(-37.4%) |
Sept 2006 | - | -$50.50 K(-226.3%) | $92.20 K(-35.4%) |
June 2006 | - | $40.00 K(+281.0%) | $142.70 K(+146.5%) |
Mar 2006 | - | $10.50 K(-88.6%) | $57.90 K(-37.2%) |
Dec 2005 | $92.20 K(-70.4%) | $92.20 K(-305.8%) | $92.20 K(-56.7%) |
June 2005 | - | -$44.80 K(-200.0%) | $213.00 K(-26.0%) |
Mar 2005 | - | $44.80 K(-85.6%) | $288.00 K(-7.4%) |
Dec 2004 | $311.10 K(+25.6%) | $311.10 K(-417.1%) | $311.00 K(+278.8%) |
Sept 2004 | - | -$98.10 K(-424.8%) | $82.10 K(-66.8%) |
June 2004 | - | $30.20 K(-55.5%) | $247.50 K(-19.0%) |
Mar 2004 | - | $67.80 K(-17.5%) | $305.50 K(+23.3%) |
Dec 2003 | $247.70 K(+295.1%) | $82.20 K(+22.1%) | $247.70 K(+38.7%) |
Sept 2003 | - | $67.30 K(-23.7%) | $178.60 K(+60.5%) |
June 2003 | - | $88.20 K(+782.0%) | $111.30 K(+53.1%) |
Mar 2003 | - | $10.00 K(-23.7%) | $72.70 K(+15.9%) |
Dec 2002 | $62.70 K(+188.9%) | $13.10 K(>+9900.0%) | $62.70 K(+26.4%) |
Sept 2002 | - | $0.00(-100.0%) | $49.60 K(-25.0%) |
June 2002 | - | $49.60 K(>+9900.0%) | $66.10 K(+204.6%) |
Dec 2001 | $21.70 K(-89.7%) | $0.00(-100.0%) | $21.70 K(0.0%) |
Sept 2001 | - | $16.50 K(+217.3%) | $21.70 K(+317.3%) |
June 2001 | - | $5200.00 | $5200.00 |
Dec 1998 | $211.40 K(+121.6%) | - | - |
Dec 1997 | $95.40 K(+500.0%) | - | - |
Dec 1996 | $15.90 K(+50.0%) | - | - |
Dec 1995 | $10.60 K(-84.9%) | - | - |
Dec 1994 | $70.40 K(-21.8%) | - | - |
Dec 1993 | $90.00 K | - | - |
FAQ
- What is the all time high annual CAPEX for TherapeuticsMD?
- What is the all time high quarterly CAPEX for TherapeuticsMD?
- What is the all time high TTM CAPEX for TherapeuticsMD?
What is the all time high annual CAPEX for TherapeuticsMD?
TherapeuticsMD all-time high annual capital expenditures is $23.89 M
What is the all time high quarterly CAPEX for TherapeuticsMD?
TherapeuticsMD all-time high quarterly capital expenditures is $20.73 M
What is the all time high TTM CAPEX for TherapeuticsMD?
TherapeuticsMD all-time high TTM capital expenditures is $23.89 M